BioVie Inc. Form 10-K: Annual report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-08-13: Form 10-K; Period of report 2026-06-30; Description FORM 10-K FOR PERIOD ENDED JUNE 30, 2026; Document bivi-20260630_10kv8.htm.
- 2025-08-15: Form 10-K; Period of report 2025-06-30; Description FORM 10-K; Document bivi-20250630_10k.htm.
- 2024-09-30: Form 10-K; Period of report 2024-06-30; Description 10-K; Document bivi-20240630_10k.htm.
- 2023-08-16: Form 10-K; Period of report 2023-06-30; Description 10-K; Document bivi-20230630_10k.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-08-13 | 10-K | 2026-06-30 | FORM 10-K FOR PERIOD ENDED JUNE 30, 2026 | bivi-20260630_10kv8.htm |
| 2025-08-15 | 10-K | 2025-06-30 | FORM 10-K | bivi-20250630_10k.htm |
| 2024-09-30 | 10-K | 2024-06-30 | 10-K | bivi-20240630_10k.htm |
| 2023-08-16 | 10-K | 2023-06-30 | 10-K | bivi-20230630_10k.htm |
| 2022-09-27 | 10-K | 2022-06-30 | 10-K | bivi-20220630_10k.htm |
| 2021-08-30 | 10-K | 2021-06-30 | FORM 10-K | bivi-20210630_10k.htm |
| 2020-08-06 | 10-K | 2020-06-30 | FORM 10-K FOR PERIOD ENDING JUNE 30, 2020 | bivi-20200630_10k.htm |
| 2019-09-27 | 10-K | 2019-06-30 | FORM 10-K FOR PERIOD ENDING JUNE 30, 2019 | bivi-20190630_10k.htm |
| 2018-10-05 | 10-K | 2018-06-30 | FORM 10-K FOR PERIOD JUNE 30, 2018 | bivi-20180630_10k.htm |
| 2017-08-24 | 10-K | 2017-06-30 | FORM 10-K FOR PERIOD ENDED JUNE 30, 2017 | bivi-20170630_10k.htm |
| 2016-09-28 | 10-K | 2016-06-30 | FORM 10-K FOR PERIOD ENDED JUNE 30, 2016 | bivi-20160630_10k.htm |
| 2015-10-01 | 10-K | 2015-06-30 | FORM 10-K FOR PERIOD ENDED JUNE 30, 2015 | nnab-20150630_10k.htm |
| 2014-09-24 | 10-K | 2014-06-30 | FORM 10-K | nnab-20140630_10k.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |